首頁 > 市場調查報告書 > 醫療設備

導管醫學影像診斷 CT/MRI/X光

磁振造影導引神經外科消融市場規模、佔有率和成長分析（按產品、適應症、最終用途和地區分類）：產業預測（2026-2033 年）

市場調查報告書

商品編碼

1898169

磁振造影導引神經外科消融市場規模、佔有率和成長分析（按產品、適應症、最終用途和地區分類）：產業預測（2026-2033 年）

MRI-Guided Neurosurgical Ablation Market Size, Share, and Growth Analysis, By Product (MRI Guided Laser Ablation Systems, MRI Guided RF Ablation Systems), By Indication (Tumors, Epilepsy), By End-Use, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月23日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計 2024 年 MRI 導引神經外科消融市場規模將達到 6.3543 億美元，從 2025 年的 6.8436 億美元成長到 2033 年的 12.3882 億美元，在預測期（2026-2033 年）內複合年成長率為 7.7%。

受神經系統疾病和腦腫瘤發生率上升以及微創手術技術發展趨勢的推動，磁振造影引導神經外科消融術市場正經歷強勁成長。患者青睞此類手術，因為外科醫生可以使用專用器械最大限度地減少組織損傷，從而縮短恢復時間並降低手術風險。即時高解析度磁振造影技術的創新顯著提高了手術的準確性和安全性，增強了術中可視化和適應性。此外，四束追蹤等技術的進步也提高了治療藥物難治性震顫等疾病的能力。這一市場成長反映出，越來越多的醫療專業人士認知到微創技術在神經外科領域相較於傳統方法所具有的諸多優勢。

磁振造影導引神經外科消融術市場促進因素

神經系統疾病的日益普遍是推動磁振造影引導神經外科消融術需求成長的主要因素。多種影響神經系統的疾病可導致危及生命的狀況和嚴重的殘疾。隨著人們對這些疾病的認知不斷提高，對有效治療方法的需求也日益成長。在此背景下，磁振造影導引神經外科消融術等創新方法因其在標靶腦內病灶的有效性和精準性而備受關注。對先進治療技術的日益重視反映了醫療保健領域的一個更廣泛趨勢，即採用最尖端科技來改善患者預後並應對神經系統疾病的複雜性。

磁振造影引導神經外科消融術市場限制因素

磁振造影導引神經外科消融術市場面臨許多限制因素，主要源自於保險覆蓋範圍和報銷方面的挑戰。儘管這些創新手術為神經系統疾病患者提供了寶貴的治療選擇，但保險覆蓋範圍和報銷政策的差異可能會給尋求治療的患者帶來巨大的經濟障礙。在許多情況下，保險公司無法全額報銷磁振造影導引神經外科消融術的費用，導致患者需要承擔高額的自付費用，這可能會成為選擇治療方案的障礙。此外，不同地區和保險計劃之間缺乏標準化的報銷流程，進一步加劇了財務困境，導致患者獲得治療的機會不均等，並可能阻礙這項先進技術的廣泛應用。解決這些挑戰對於改善磁振造影引導神經外科消融術的可及性以及促進其融入傳統醫療保健體系至關重要。

磁振造影導引神經外科消融術市場趨勢

磁振造影導引神經外科消融市場正日益受到以病人為中心的醫療模式的影響。這種模式優先考慮根據每位患者的獨特需求和意願量身定做的個人化治療方法。該模式透過專注於個人化的治療計劃來提升醫療質量，這些計劃充分考慮了患者的具體病情和特徵，從而實現微創且精準的手術。透過營造協作和共同決策的氛圍，患者能夠積極參與自身的醫療保健過程。這種對個人化的重視不僅改善了患者的體驗和滿意度，也與神經外科向更具適應性和回應性的醫療服務模式的全面轉變相契合，最終帶來更好的臨床療效。

Monteris Medical（美國）
InSightec有限公司（以色列）
加拿大普羅芬德醫療公司
Medtronic plc（Ireland）
波士頓科學公司（美國）
AngioDynamics公司（美國）
ClearPoint Neuro公司（美國）
Elekta AB（Sweden）
Accuray 公司（美國）
Brainlab AG（德國）
瓦里安醫療系統（美國）
雅培實驗室（美國）
西門子醫療股份公司（德國）
飛利浦醫療保健（荷蘭）
GE醫療（美國）

結論與建議

簡介目錄

Product Code: SQMIG35H2181

MRI-Guided Neurosurgical Ablation Market size was valued at USD 635.43 Million in 2024 and is poised to grow from USD 684.36 Million in 2025 to USD 1238.82 Million by 2033, growing at a CAGR of 7.7% during the forecast period (2026-2033).

The MRI-guided neurosurgical ablation market is experiencing robust growth driven by the rising prevalence of nervous system disorders and brain tumors, alongside a shift towards minimally invasive surgical techniques. These approaches are favored by patients due to their potential for quicker recovery and reduced surgical risks, as surgeons utilize specialized instruments to minimize tissue damage. Innovations in real-time, high-resolution MRI have significantly enhanced the precision and safety of these procedures, enabling better visualization and adaptation during surgery. Additionally, advancements such as four-tract tractography are improving treatment capabilities for conditions like medication-resistant tremors. This market growth reflects a growing endorsement from medical professionals who recognize the myriad benefits of minimally invasive techniques over traditional methods in neurosurgery.

Top-down and bottom-up approaches were used to estimate and validate the size of the MRI-Guided Neurosurgical Ablation market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

MRI-Guided Neurosurgical Ablation Market Segments Analysis

Global MRI-Guided Neurosurgical Ablation Market is segmented by Product, Indication, End-Use and region. Based on Product, the market is segmented into MRI Guided Laser Ablation Systems, MRI Guided RF Ablation Systems, MRI Guided Focused Ultrasound Systems and Accessories. Based on Indication, the market is segmented into Tumors, Epilepsy, Pain Management and Vascular Malformations. Based on End-Use, the market is segmented into Hospitals, Clinics and Ambulatory Surgical Centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the MRI-Guided Neurosurgical Ablation Market

The growing prevalence of neurological disorders significantly drives the demand for MRI-guided neurosurgical ablation. Various diseases affect the nervous system, leading to conditions that can be life-threatening or result in severe disabilities. As awareness of these disorders rises, so does the need for effective treatment options. Among these, innovative approaches such as MRI-guided neurosurgical ablation are gaining traction, owing to their efficacy and precision in targeting affected areas within the brain. This increased focus on advanced therapeutic techniques reflects a broader trend in healthcare, where cutting-edge technologies are being embraced to enhance patient outcomes and address the complexities of neurological health.

Restraints in the MRI-Guided Neurosurgical Ablation Market

The MRI-guided neurosurgical ablation market faces significant constraints primarily due to insurance and reimbursement challenges. Although these innovative procedures offer valuable treatment options for individuals with neurological disorders, the variability in insurance coverage and reimbursement policies can create substantial financial obstacles for patients seeking these interventions. In many cases, insurance providers may offer incomplete coverage for the costs associated with MRI-guided neurosurgical ablation, resulting in considerable out-of-pocket expenses for patients, which may deter them from pursuing such treatments. Moreover, the absence of standardized reimbursement practices across different regions and insurance plans complicates the financial landscape, leading to disparities in patient access and potentially hindering the widespread adoption of this advanced technology. Tackling these issues is essential for improving access to MRI-guided neurosurgical ablation and facilitating its integration into conventional healthcare systems.

Market Trends of the MRI-Guided Neurosurgical Ablation Market

The MRI-guided neurosurgical ablation market is increasingly influenced by the trend of patient-centric care, which prioritizes individualized treatment approaches tailored to each patient's unique needs and preferences. This model enhances the quality of care by focusing on personalized treatment plans that consider the specific medical conditions and characteristics of patients, allowing for minimally invasive and precisely targeted procedures. By fostering a culture of collaboration and shared decision-making, patients become active participants in their healthcare journeys. This emphasis on personalization not only improves patient experiences and satisfaction but also aligns with the overarching shift towards more adaptive and responsive healthcare services within the neurosurgical field, ultimately driving positive clinical outcomes.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Landscape
Case Studies

Global MRI-Guided Neurosurgical Ablation Market Size by Product & CAGR (2026-2033)

Market Overview
MRI Guided Laser Ablation Systems
MRI Guided RF Ablation Systems
MRI Guided Focused Ultrasound Systems
Accessories

Global MRI-Guided Neurosurgical Ablation Market Size by Indication & CAGR (2026-2033)

Market Overview
Tumors
Epilepsy
Pain Management
Vascular Malformations

Global MRI-Guided Neurosurgical Ablation Market Size by End-Use & CAGR (2026-2033)

Market Overview
Hospitals
Clinics
Ambulatory Surgical Centers

Global MRI-Guided Neurosurgical Ablation Market Size & CAGR (2026-2033)

North America (Product, Indication, End-Use)
- US
- Canada
Europe (Product, Indication, End-Use)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product, Indication, End-Use)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product, Indication, End-Use)
- Brazil
- Rest of Latin America
Middle East & Africa (Product, Indication, End-Use)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Monteris Medical (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
InSightec Ltd. (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Profound Medical Corp. (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boston Scientific Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AngioDynamics Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ClearPoint Neuro, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Elekta AB (Sweden)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Accuray Incorporated (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Brainlab AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Varian Medical Systems (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens Healthineers AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Philips Healthcare (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GE Healthcare (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments